Quad Marker test With Graph (For Priority Users) near me in Muzaffarpur
Understanding Quad Marker test With Graph (For Priority Users) in Muzaffarpur
What is Quad Marker test With Graph (For Priority Users) in Muzaffarpur?
A Quad Marker test With Graph (For Priority Users) test is the most common blood screening test done between the 14th and 22nd weeks (ideal 15-20 weeks, i.e., second trimester) of pregnancy to determine whether the baby is at risk for certain birth defects. It offers valuable information to ensure the well-being of both the mother and the unborn child.
A Quad Marker test With Graph (For Priority Users) test is a prenatal screening test tailored to provide expectant parents with insights into the developing baby's health. It analyzes specific markers in the mother’s blood to assess the risk of chromosomal abnormalities, such as Down Syndrome (Trisomy 21) and Edwards Syndrome (Trisomy 18), wherein extra copies of chromosome 21 and 18 are present and affect the baby's physical and intellectual development. It also screens for neural tube defects like spina bifida (a spinal cord defect) and anencephaly (a brain defect). These birth defects can result in nerve damage, learning disabilities, paralysis, or stillbirth.
The Quad in Quad Marker test With Graph (For Priority Users) test refers to the four specific markers measured in the mother’s blood during the screening. These include Alpha-fetoprotein (AFP), Human Chorionic Gonadotropin (hCG), Estriol Unconjugated (uE3), and Inhibin A. When assessed collectively, the levels of these markers help estimate the likelihood of certain fetal abnormalities that can affect the baby’s growth and development. Timely detection of these abnormalities is vital for ensuring comprehensive prenatal care and effectively addressing potential health problems. In addition to the traditional Quad marker analysis, the inclusion of a graphical representation enhances the interpretability of results.
A Quad Marker test With Graph (For Priority Users) test is a screening test only; any abnormal result does not mean the unborn baby has a birth defect or genetic condition. It only tells whether the unborn baby is at risk of developing certain abnormalities, and further testing is required to confirm the diagnosis.
The recommendation of a Quad Marker test With Graph (For Priority Users) test is often based on maternal age, medical history, and individual risk factors for chromosomal abnormalities. Pregnant women should consult their doctor to determine the most appropriate screening or diagnostic test based on their specific circumstances.
What does Quad Marker test With Graph (For Priority Users) measure?
Contains 4 testsInhibin A
The Inhibin A test measures the level of inhibin A in the blood. It is a hormone primarily produced by the ovaries in women. It plays a key role in regulating menstrual cycle and ovarian function by inhibiting the production of follicle-stimulating hormone (FSH). During pregnancy, elevated levels of Inhibin A may point towards a risk of certain chromosomal abnormalities like Down’s syndrome etc., in the fetus.
The Inhibin A test is particularly useful in assessing ovarian function, fertility assessment, prenatal screening and diagnosing certain ovarian cancers.
Know more about Inhibin A
HCG Beta Total Quantitative, Maternal
An HCG Beta Total Quantitative, Maternal test measures the levels of human chorionic gonadotropin (hCG) hormone in the blood. hCG is released in the blood during pregnancy and can be detected as early as 10 days after conception. The levels of this hormone gradually rise every 2 to 3 days (or 48 to 72 hours) and peak around 8 to 11 weeks after conception. After reaching the peak, the hCG levels decrease and remain steady for the rest of the pregnancy.
Know more about HCG Beta Total Quantitative, Maternal
Alpha Feto Protein, Maternal
An Alpha Feto Protein, Maternal test measures the amount of Alpha Fetoprotein in expectant mothers usually during the second trimester (14th and 22nd weeks). AFP is a protein produced by the fetus, primarily by the fetal liver and yolk sac, and it passes into the mother's blood. The test is typically performed to screen for certain fetal abnormalities, particularly neural tube defects (NTDs) such as spina bifida and anencephaly, as well as chromosomal abnormalities like Down syndrome (trisomy 21), Edwards syndrome (Trisomy 18), etc.
Detecting these abnormalities early in pregnancy allows for appropriate medical management and intervention.
Know more about Alpha Feto Protein, Maternal